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Several countries have recently introduced maternal health care fee exemptions 
as a quick win approach to reach MDG 5 goals. It has also been argued that 
these policies were relevant first steps towards universal health coverage 
(UHC). The scope and contents of the benefits package covered by these policies 
vary widely. First evaluations raised questions about efficiency and equity. This 
article offers a more comprehensive view of these maternal health fee 
exemptions in Africa. We document the contents and the financing of 11 of these 
policies. Our analysis highlights (1) the importance of balancing different risks 
when a service is the target of the policy – C-sections address some of the main 
catastrophic costs, but do not necessarily address the main health risks to 
women, and (2) the necessity of embedding such exemptions in a national 
framework to avoid further health financing fragmentation and to reach UHC. 
 
INTRODUCTION 
 
In recent years, African countries have experienced a strong political dynamic to 
improve financial access to public health service.1-3 In the early 2000s, user fee 
exemption policies were initiated for specific pathologies (HIV, malaria, and 
tuberculosis) or priority groups of people (pregnant women, children under five). 
There is growing evidence that user fee removal is a strategy that can improve 
service utilization.4-5 A large number of countries have put in place maternal 
health fee exemptions as a quick win approach to reach the Millennium 
Development Goal (MDG) 5 (maternal mortality reduction).6 While such 
initiatives can be seen as real opportunities to accelerate progress towards UHC 
both at the national and the global level,7 they also raise specific challenges.8 The 
scope and content of the benefits package covered by these policies seems to vary 
widely, with some countries covering Caesarean sections only, while others aim 
to cover a more comprehensive set of maternal health services – it is not clear 
whether selection of services was based on expert maternal health advice. There 
is also evidence that user fee removals are often driven by political objectives with 
insufficient consultation of technical experts, i.e. while political ownership at the 
national level is strong, technical governance is inadequate.9 Available evidence 
on the impact of these policies raises some questions about efficiency and 
equity.10-13 In the context of limited resources, the financing and sustainability of 
these policies also poses a challenge.14 These are matters of concern for 
technicians and health care providers managing the daily implementation of 
these exemption policies in the field.15-16 
 This article aims at gathering a more comprehensive view on these 
maternal health fee exemptions in Africa. We document the contents and the 
financing of 11 of these policies and discuss the lessons that arise. We identify the 
main challenges faced by these policies, a few governance issues and perspectives 
in terms of their possible contribution to UHC.  
 
Background 
 
In May 2009, some international agencies i  met in the framework of 
Harmonization for Health in Africa (HHA) and agreed on better coordination of 
their efforts in managing knowledge and their support to health systems and 
health policy. A community of practice (CoP) strategy was adopted.17 The driving 
idea behind this strategy is to promote and capitalize on the knowledge and 
experience of the African experts. In November 2010, HHA agencies, with some 
15 African countries, jointly agreed to establish a CoPii on the issue of financial 
access to health services (FAHSCOP).  
 The first CoP-organized technical workshop on the topic of maternal fee 
exemptions was held in Bamako in November 2011. The workshop addressed 
operational issues and brought together 70 people working on the issue of 
maternal health and its financing from more than 10 African countries: national 
experts from Ministries of Health, maternal health care providers, researchers, 
civil society representatives, and partners working on the topic, as well as 
members of the CoP. Six Francophone countries (Benin, Burkina Faso, Mali, 
Morocco, Niger, and Senegal) and four Anglophone countries (Ghana, Kenya, 
Nigeria, and Sierra Leone) were represented. The selection of countries selection 
was based on (1) the existence of an on-going national maternal health fee 
exemption policy, (2) a balance between French and English countries, and (3) 
available financial support for the participation of technicians, researchers, and 
civil society representatives. To prepare for the workshop, questionnaires were 
sent to all the participating countries (11 countries) to compare the benefits 
package and the funding modalities of these fee exemption policies. The objective 
of this article is to present a comparative analysis of country policies, based on 
these questionnaires. While there have been many studies of individual country 
policies in the past, this analysis provides a more comprehensive understanding 
of the scale, scope, and approach of current maternal fee exemption policies 
across the continent.  
 
METHODS 
 
A key principle of CoPs is to favour co-development of knowledge. This study 
relied on such a participatory approach, as it is practitioners – and more 
specifically cadres in charge of the policies under study – who provided the data 
and validated them.  
 
Data Collection 
 
A questionnaire was developed by health economists and maternal health 
researchers and validated by the workshop organizing committee. The 
questionnaire had two purposes: to establish the contents of the benefits package 
covered, as well as its funding modalities. A pre-test was done in Burkina Faso, 
working with the person in charge of the national subsidy for deliveries and 
emergency obstetrical and neonatal care. In September 2011, questionnaires were 
sent to the key informants in the 11 countries (key informants were people in 
charge of monitoring the policies). Where information was lacking, researchers 
who had studied these policies in the countries helped to fill in the 
questionnaires. Follow-up with key informants was done by telephone and email. 
Completed questionnaires were reviewed by experts in the field to identify any 
inconsistencies; if needed, further clarification was sought from the country.  
 
Data Analysis 
 
Country data were entered and analysed with Excel. Benefits packages were 
compared across the World Health Organization’s (WHO) three dimensions of 
universal coverage: population, services, and costs coverage.18 Individual country 
analyses and the comparative tables were reviewed and validated by country key 
informants during the CoP Bamako workshop.  
 In order to make the international comparisons easier we have converted 
local currencies using Purchasing Power Parities (PPPs).iii  
 
Study Limitations  
 
The sample was not comprehensive, as we did not include all sub-Saharan 
African countries that have introduced a maternal health fee exemption policy. 
Only countries attending the workshop were asked to complete the questionnaire. 
Eleven countries completed the questionnaire, but only ten attended the Bamako 
workshop (the Burundi delegation was not able to come). 
 As researchers were unable to go to the field to collect the data, the 
questionnaire was sent by email to key informants. Part one of the questionnaire 
regarding the composition of the benefits package covered by the policy was 
generally completed, but there were some gaps in the information provided in 
part two on the policies’ financing. All financial information was collected for 
2010 with the exception of Mali, Niger, and Nigeria. For Niger, data were 
provided for 2009, while the data for Nigeria on the policy costs cover the period 
from November 2008 to June 2010. For Mali, no financial information was 
obtained via the questionnaire. The data for Mali comes from the 2011 USAID 
evaluation report.19 The information on the total cost of the exemption policy was 
not available in Ghana and Senegal.iv It was not possible to obtain data about the 
total amount of external funding used to support the exemption policy in Sierra 
Leone. External funding was done via budget support (to the national budget) 
and thus an estimate of the total amount of development funds used to indirectly 
support the programme was not possible.  
 More generally, there are limitations inherent in a one-off cross sectional 
survey, particularly in describing policies that are dynamic and embedded in 
changing health systems. 
  
RESULTS 
 
Timing of Introduction 
 
The 11 policies were introduced between 2004 (Ghana) and 2010 (Sierra Leone). 
As shown in Figure 1, most have gone through a number of iterations (extending 
the geographical area covered, changing the benefits package and/or changing 
the delivery mechanisms and co-payments). For example, Senegal’s fee 
exemption policy started in 2005 in five poor regions and was extended one year 
later to the rest of the country (except Dakar). In Burundi, the policy started in 
2006 by covering children under 5, normal deliveries and Caesarean sections. In 
2009, pregnancy-related diseases were added to the package of services 
exempted. 
 
Figure 1: Chronology of the Policies’ Introduction (n=11) 
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Benefits Packages 
 
1. Who is covered? 
 
Coverage involves several elements, including the population sub-group 
included, whether any income-based targeting is applied, the geographical areas 
covered, and the sectors included in the policy (see Table 1). The Benin, Mali, and 
Senegal policies cover only care for pregnant women while other countries also 
include care for the newborn. In Kenya, Nigeria, and Senegal, the policy covers 
targeted regions and not the whole country. Five countries apply the policy only 
in the public sector, while six countries have extended the policy to not-for-profit 
facilities, and even for-profit facilities with an accreditation process. The majority 
of policies apply to the entire population of pregnant woman regardless of their 
income, except for Kenya (whose policy targets poor pregnant women). 
 
 
Table 1: Target Population of the Policies (n=11) 
 Country Target group 
 
Eligibility 
criteria based 
on income 
Geographical 
coverage 
Type of 
health 
facilities 
Benin 
 
Pregnant women with 
complications 
NO National Public & non-for-profit 
Burkina-
Faso 
 
Pregnant women (all) + new 
born with complication 
NO National Public & non-for-profit 
Burundi Pregnant women + new born NO National Public & non-for-profit 
Ghana Pregnant women + new born NO National Accreditation (all types) 
Kenya Pregnant women + new born For poor women only Targeted regions 
Accreditation 
(all types) 
Mali Pregnant women with complications NO National Public 
Morocco Pregnant women + new born NO National Public 
Niger 
 
Pregnant women with 
complications / new Born 
NO National Public 
Nigeria Pregnant women + new born NO Targeted regions Accreditation (all types) 
Senegal Pregnant women NO National (except Dakar) Public 
Sierra 
Leone 
Pregnant women + new born 
/lactating mother (with 
children under two) 
NO National Public 
 
2. Which services are covered? 
 
The only service that is covered by all 11 countries is provision of C-sections 
(Table 2). Eight of 11 countries cover normal deliveries.v Two countries do not 
cover obstetric complications during pregnancy and labour, and four countries do 
not cover the complications during the post-partum. 
 Three categories of countries can be drawn from the table: (1) countries 
with a very comprehensive package (Burkina Faso, Burundi, Ghana, Morocco); 
(2) countries with a fairly comprehensive package, but that do not cover the 
complications related to abortion care (Kenya, Nigeria, Sierra Leone); and the 
last category: (3) countries with a very limited range of exempted services (Mali, 
Niger, Benin). 
 
 
Table 2: Services Covered by the Policies (n=11) 
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Antenatal	  care
Delivery
Episiotomy
Complication	  during	  pregnancy DC DC DC
Complication	  during	  labour
Caesarean	  section
Other	  surgeries Hyster. Hyst+Ect.P Hyst+Ect.P
Postnatal	  care
Postnatal	  complication
Postnatal	  family	  plnning
Simple	  post-­‐abortion	  care
Complicated	  post-­‐abortion	  care
Newborn	  care
Covered	  by	  another	  exemption	  or	  subsidy	  policy  
Note: DC=direct obstetric complications, hyster=hysterectomy, ect. p=ectopic pregnancy 
 
3. Which types of cost are covered?  
 
Figure 2 shows the types of costs covered by the policies. Surgical costs and 
hospitalisation costs are covered by all the policies, but complementary 
examinations like radiology, ultrasound, and even laboratory tests are not 
universally covered. 
 Few policies (five) cover the transport cost between health facilities. Only 
Morocco covers the transport cost between home and the health facilities (and 
that only in 24 provinces with poor access over 85 provinces). The range of costs 
covered is better for the mother than for the newborn. Under all policies, some 
household costs remain.  
 
Figure 2: Costs Covered by the Fee Exemption or Subsidy Policies (n=11) 
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The majority of countries cover 100% of the direct costs of targeted services 
under the policy. Only two countries require some co-payment for the direct costs 
of targeted services: Burkina Faso (20% of direct costs are paid by the household) 
and Kenya (which demands a contribution of $1- 2 per voucher. The voucher 
gives access to maternal health services: facility delivery or management of 
complications). Some countries have put in place a system of differing 
reimbursement levels to avoid self-referral to higher levels of the health pyramid. 
For example, in Burkina Faso, 80% of normal delivery costs are reimbursed in 
health centres, but only 60% in university hospitals. In Morocco, the exemption 
policy is applied in university hospitals for referred women only.  
 
How Exemption Policies for Maternal Health are Linked with the Other 
Initiatives? 
 
Exemption policies for maternal and neonatal care are not unique but one of a 
growing number of fee exemptions in many countries, which often have parallel 
policies targeting other disease or population groups (Table 3). Most countries 
also have a national policy to exempt the indigent from paying direct health care 
costs, but very often, they are not implemented in practice. Parallel to these 
initiatives, several countries (e.g. Ghana, Nigeria, and Kenya) have put in place a 
national health insurance system, while others are in the process of developing 
one (Mali, Benin). 
 
Table 3: Other Targeted Exemption Policies 
(n=11)
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<	  5	  years	  
preventive
s	  care
<	  5	  ans	  
TB/Malaria
/HIV
Ederly	   TB Malaria HIV
Family	  
planning Other
Benin Leprosy,	  Ulcer	  and	  Buruli,	  Onchocerciasis
Burkina-­‐Faso Surgical	  emergency
Burundi
Ghana* Psychiatric	  cases
Kenya Séquelae	  sexual	  violence
Mali
NTDs,	  Leprosy,	  cervical	  cancer,	  
Onchocerciasis,…
Morocco Mammography,	  Iron	  deficiency	  Anemia	  
Niger Women's	  cancer
Nigeria
Senegal
Sierra	  Leone Leprosy
Total 7 8 3 9 7 9 74
Trageted	  population	  group Targeted	  diseases	  or	  services	  
Countries <	  5	  years	  
curatives	  
care
 
POLICY COSTS AND FUNDING MODALITIES 
 
Revenue Collection 
 
Funding sources for the fee exemption policy vary between countries. Some 
countries have relied solely on internal resources (Benin, Ghana, Mali, Morocco, 
Nigeria, Senegal), while others (Burkina Faso, Burundi, Kenya, Niger, Sierra 
Leone) rely on co-funding (at least to some extent) by development partners 
(Figure 3). With the exception of Kenya (whose policy - still a pilot project 
operating only in certain regions and parts of Nairobi - relies almost entirely on 
external funding  from KfW -  external funding accounts for a relatively small 
portion of funding of fee exemption policies (around 20% for Burundi and Niger, 
and less than 1% for Burkina Faso). Other countries, notably Sierra Leone, rely 
heavily on budget support funds to support the implementation of the fee 
exemption policy, even though they are not directly allocated to this programme 
as such. 
 Some countries have used resources from the HIPC (Heavily Indebted 
Poor Countries Initiative) to co-fund their fee exemption policies, as was the case 
in Nigeria, Ghana (phases 1 and 2), Burundi, and Senegal. 
 
Figure 3: Share of External Funding in the Exemption Policy Funding (n=4) 
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External assistance is primarily, but not exclusively, monetary. In the case of 
Niger, for example, external funding is channelled through several mechanisms: 
provision of funding (AFD), drug supply (AFD, WHO, UNFPA, UNICEF) and 
contraceptive commodities (UNFPA), and medical transport for referral (NGO 
HELP). Like Niger, the fee exemption policy in Burundi and Sierra Leone is 
supported by a multiplicity of donors. In the case of Sierra Leone, the most 
prominent are DFID (the UK Department for International Development), the 
World Bank, the African Development Bank, and UNFPA. All of these partners 
bring substantial technical support, as well as funding. 
 The length of donor commitment to funding fee exemption policies varies 
from country to country. In Burundi and Kenya, donors have made a financial 
commitment until 2014 (in Kenya, 344 million Kenyan shillings per year is 
committed until November 2014). For Niger and Sierra Leone, the period of 
donors’ financial commitment was not provided. In Burkina Faso, donors have 
made no commitments but their support is marginal compared to the 
government’s financial efforts. 
 Beyond the question of donors’ financial commitments to support these 
policies lies the critical issue of sustainability. This is certainly the case in Kenya, 
whose policy is heavily dependent on external funding. In several countries, the 
policy has a flagship status for the president; in Burundi for instance, the 
president seems committed to protect his initiative (the country is even about to 
launch a national scheme to cover other categories of the population). But such 
political commitment can also encounter the difficult reality of budget 
constraints. Niger recently organised a national conference to assess the fee 
exemption policy: the 160 participants at the conference declared that “the fee 
exemption policy was seriously sick and must be saved.”vi The First Minister 
promised the creation of a fee exemption policy coordination body reporting to 
the First Minister’s cabinet, as well as political commitment to address serious 
policy failures (underfunding, delays in reimbursement of the health facilities, 
poor management of the drugs supply chain, etc). Burkina Faso is the only 
country surveyed with an explicit multi-year commitment to finance the fee 
exemption policy (till 2015). 
 
Pooling 
 
In the 11 countries, these policies are funded by a single pool funded by tax payers 
or aid agencies; only Burkina Faso policy still stipulate that households have to 
cover 20% of the cost.20 The entitlement is offered to all pregnant women in 8 of 
the 11 countries (Table 1). The three other countries have tried to implement a 
targeted approach to enhance the equity of the scheme, either by a focus on the 
poorest (Kenya) or on less rich regions (Kenya and Senegal). This indicates an 
overall equitable pooling of resources. 
 If there is inequity in terms of benefit-incidence, it might have two 
sources: (1) the barriers encountered by the poorest to access the services and (2) 
possible transfer of resources from this pool to another pool. It was not the 
purpose of this rapid study to enter these questions requiring substantial data 
collection. One can only hypothesise that a country whose policy covers also some 
of these barriers (e.g. Morocco and its broad assistance for transport) will fare 
better than a country whose policy leaves a small user fee by the user (e.g. 
Burkina Faso) or does not cover the transport (e.g. Niger).  
 
 
Purchasing 
 
Funding Modalities 
 
Most countries pay facilities according to the number of services provided, 
though some pay in advance and others in arrears, and in some cases kits are an 
important component of the support to facilities. Benin, Burkina Faso, Burundi, 
Ghana, Kenya, Niger, and Nigeria pay retrospectively per service. In Mali, the 
supply of C-section kits is handled on a biannual basis and the reimbursement of 
health facilities is done on a quarterly basis. In Morocco and Senegal, 
prepayment of health facilities is done on an annual basis (for regional hospitals 
only in Senegal) in combination with the provision of delivery kits and medicines 
(Morocco) and C-section kits at the level of health centres in Senegal.  
 
Different Levels of Reimbursement  
 
Almost all countries have developed fixed reimbursement rates per service 
exempted, with the exception of Burkina Faso, which reimburses actual costs 
(retrospective fee for service payment to facilities). Some countries have varying 
reimbursement rates according to level of care (district/regional/national 
hospital) and type of facilities (public/non-for-profit/for-profit facilities); cost 
differences between levels of care are taken into account, with higher level 
facilities receiving higher funding. In Niger, for example, the reimbursement of a 
C-section in 2010 was $320.6 PPP in a national hospital, $200 PPP in a regional 
hospital, and $140.2 PPP in a district hospital. 
 In another set of countries, the reimbursement rate depends on facility 
ownership alone. In Kenya, for example, in 2010 a C-section reimbursement was 
$224 PPP in public health facilities, $579.8 PPP in a faith-based or NGO facility 
and $1040.5 PPP in accredited private hospitals. In a third set of countries, the 
reimbursement rate is fixed according to a combination of level of facility and its 
ownership. In Ghana, the reimbursement of health facilities is calculated using 
the National Health Insurance Scheme (NHIS) schedule. In five countries (Benin, 
Mali, Morocco, Nigeria, Senegal), there is a single rate regardless of the level or 
type of care. In Benin, all facilities performing C-sections are reimbursed $426 
PPP per C-section. In Nigeria, there is a mixed reimbursement mechanism: 
reimbursement based on outputs as well as a fixed amount of financial support 
per capita (based on the number of persons registered in the Health Management 
Organisation). 
 The extent to which the reimbursement rates are based on a real 
understanding of cost structures or costing studies is unclear. Previous studies 
have highlighted some differences between the cost of services and 
reimbursement rates.21 In Benin, the reimbursement is thought to be over-
generous for district hospitals but not sufficient for the university hospitals 
(situational analysis of FEMHealth project in Beninvii).  
  
 
Cost of Maternal Exemptions 
 
There is of course wide variation among countries in terms of the overall cost of 
the fee exemption policy, from $62.8 million PPP in Morocco to $4.8 million PPP 
in Niger. Size of the population, economic development, scope of the benefit 
package, and also commitment by the government, are all factors affecting the 
budget available for the policy. The most interesting comparison is in relative 
terms. 
In Figure 4, the costs of the fee exemption policy per national capita are 
shown, according to gross national income (GNI) per capita. To facilitate 
comparison, policies have been presented in three groups according to their 
target population (pregnant women, pregnant women and newborns, pregnant 
women and children under 5). It is clear that the spending per capita is not well 
correlated with national income. These variations reflect a variety of factors, 
including differing entitlements within the policies, differing degrees of effective 
implementation, as well as different demographic factors, coverage levels, cost 
structures, and resource availability. Burundi is making the greatest effort 
relatively to nation’s wealth.  
 
Figure 4: Exemptions Policy Costs per capita, by GNI per capita (n=9) 
 
 
 
We were able to obtain cost information for C-sections in seven countries (Figure 
5), which varied substantially. In 2010, the direct unit cost of a C-section 
(surgical kits, drugs, inpatient stay) in Benin was estimated at $426 PPP. This 
estimate is well above the estimates of Morocco ($333 PPP) and Burkina Faso 
($257 PPP). It is double the estimated cost in Niger and Mali - respectively $200 
PPP and $220 PPP per Caesarean section (in Niger, the unit cost varies with the 
level of care). These differences may partly reflect local medical cost structures, 
but may also reflect the different bargaining power of medical constituencies. 
Reimbursement systems varied across the policies and were not generally based 
on a full estimate of the costs of producing these services. 
 
Figure 5: Estimated Unit Direct Costs of a C-section (PPP $) (n=7) 
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DISCUSSION  
 
Shared Goals, Shared Timing, Shared Learning? 
 
With this review of 11 countries, we can see that there has been a strong 
movement over the past few years in Africa to prioritising financial access for 
maternal and child health, especially in the West African region. These shared 
goals and timing most probably have different drivers, some at global level (MDG 
5; HIPC; advocacy by some global actors for free health care), some at national 
level (national elections).22-23 There is clearly room for cross-learning between 
countries and for knowledge strategies such as regional CoPs. 
 
Understanding and Addressing the Real Costs for Households 
 
These fee exemption policies are significant steps towards increasing access to 
priority services, however it is clear from the table on costs that none of these 
policies covers all costs relating to maternal and neonatal health care. Patients 
and their families are still responsible for covering at least part of the direct costs 
(especially laboratory exams, X-rays, and care of the newborn). Out-of-pocket 
payments can still be high in case of complementary exams.24 Transport is also a 
serious obstacle for households – both financial and practical. Only Morocco 
covers transport costs from the home to the health centre in rural areas through 
an emergency obstetrical and neonatal transport system (SAMU), and only five 
countries cover transport costs between different health care facilities (in referral 
cases).  In Mali, under the national fee exemption policy for C-sections, 
transportation is meant to be provided through existing referral systems that are 
supported by communities via solidarity funds; however since the policy’s 
implementation, community mobilisation has decreased, leaving the emergency 
transport system very weak.25  
 Even fee exemption policies that appear comprehensive on paper can 
engender high costs for households due to poor quality, uneven implementation, 
and lack of monitoring. There are many reports of informal payments to medical 
staff, prescription of brand-name drugs instead of generic drugs, and/or 
recurrent shortages of drugs in the public hospital pharmacies that require 
families to buy drugs from private pharmacies.26-28 In short, it will be impossible 
to fully reduce financial barriers and reduce maternal mortality if health care 
standards remain inadequate or services are simply unavailable.29 It is essential 
to invest in building adequate staff capacity and equipment before implementing 
such policies.30-31 Increasing the uptake of poorly staffed and low quality health 
services can also add to, rather than reduce, health risks to women, neonates and 
children.32 In a nutshell, fee exemption policies alone are probably not sufficient 
to provide an effective coverage to targeted priority groups. There is a need for a 
comprehensive strategy, such as the one, which was developed by Morocco in 
2008.33 
 
Still Insufficient Understanding of Incentive Issues 
 
The rapid survey approach did not allow us to document the incentive 
dimensions of the policies. This would clearly require more knowledge on the 
performance of the country health systems, including efficiency at health facility 
level. This limit was illustrated during the workshop by an expert discussion 
about the Benin situation. Is the over-generous reimbursement to district 
hospitals and the ‘insufficient’ reimbursement to university hospitals a good 
thing or a bad thing in terms of the general organization of the health system? In 
many African countries, misdistribution of qualified staff is a major issue: city 
hospitals poorly performing because of a plethora of staff coexist with rural 
hospitals lacking the required expertise. From the perspective of the stewards of 
the health system, paying the C-section the same price whatever the situation or 
the level of the hospital could then be a way to improve the overall efficiency. 
These incentive considerations deserve more in-depth research. 
 
The Risks of Focusing Too Exclusively on C-sections 	  
The content of the package also needs reflection. The one service covered by the 
fee exemption policy in all of the 11 countries surveyed is the cost of C-sections. 
Other obstetric complications during labour are omitted in two countries: Niger 
and Benin. Post-abortion care is not covered in seven countries. There is a need 
to align benefits packages with current global evidence on maternal health. 
 While C-sections, as surgical procedures, are expensive to families, other direct 
obstetric complications, such as treating infection and eclampsia, are also 
expensive because of the costs of drugs.34 Therefore, a policy focusing narrowly 
on making C-sections “free” does not eliminate the possibility of catastrophic 
expenses for families. It is also important to highlight that the major cause of 
maternal mortality in Africa is postpartum haemorrhage (33,9%) which cannot 
be treated by a C-section.35 Indirect causes of maternal mortality (HIV infection, 
tuberculosis, malaria, severe anaemia, others infection) represent also a 
significant part (26,6% all causes confounded – 6,2% related to HIV) and do not 
required surgery but rather good primary and secondary prevention during 
antenatal care.36-37 To dramatically reduce maternal mortality, it is essential to 
move beyond C-sections and support more comprehensive emergency obstetric 
care measures, as well as to assure qualified assistance during delivery.38 
 Studies carried out by WHO in Africa, Asia, and Latin America on modes 
of delivery and short-term outcomes for mother and newborn also show that C-
sections actually increase the risk of mortality and severe complications for the 
mother (admission to intensive care, blood transfusion, hysterectomy).39 C-
sections carried out for non-medical reasons, either before or during labour, 
place women at greater risk of mortality or severe complications, particularly in 
Africa where health care standards tend to be poor.40-41 During subsequent 
pregnancies, women who have undergone a C-section are at greater risk of 
uterine rupture or of implantation abnormalities (placenta praevia or accreta).42-
44 Implemented as an isolated measure, without other accompanying measures 
and strategies to reduce maternal mortality, a narrow “free C-section” policy may 
lead to an increase of unnecessary C-sections.  It is therefore important to 
monitor the evolution of the number of C-sections and their indications.45-46 The 
risk of supply-induced demand, particularly when C-sections are well reimbursed 
for providers, is non-negligible. 
 A general lesson for countries trying to move towards UHC by starting 
with schemes targeting priority groups (see below) is that it is crucial to involve 
specialised public health experts in the design of the policy.47-49 
 
Fee Exemption as a Step Toward Universal Health Coverage 
 
Whereas one can wonder whether these fee exemption policies will be enough to 
make rapid progress towards the MDG 5, there is no doubt that they are part of 
the national response to the political momentum created by the MDG agenda. As 
evidenced in the review, several countries have in fact adopted a fee exemption 
policy covering children under 5, which can be interpreted as an effort to 
accelerate progress towards MDG 4 as well.  
 As clearly stated by the WHO report50 there is no single model to progress 
towards UHC. Yates has argued that fee exemptions for children and women 
would be a major step in the right direction.51 In terms of content of the policy, 
there is no doubt that removing user fees can – if the policy is well-funded and 
implemented – significantly improve access to the health services for substantial 
groups of users. It can also improve financial protection, especially when the 
benefit package includes services, which are very costly. In terms of process, one 
can also consider that focusing first on a vulnerable group such as pregnant 
women is an equitable route to UHC. The policy extends potential benefits to all 
parts of society, which also favouring the poor, who tend to have larger families 
and are also more likely to seek care in the public sector.  
 However, physical access to facilities is a major constraint, which 
discriminates against rural households. A priority is to ensure that barriers met 
by the rural poor are really addressed – to avoid that the policy mainly finances 
the privileges of the better-off living in the cities. Some countries in our review 
have been more attentive to others to this aspect. The second one is to handle the 
articulation of the exemption fee policy with the rest of the UHC agenda. This 
aspect seems to have been less well-handled in most of the reviewed countries.  
Governance at the Country Level: Reducing Fragmentation and 
Complexity 
 
We have seen that in many countries there is a panoply of fee exemption policies 
in operation: for communicable diseases, the poor, medical staff, etc.52 These 
different initiatives lead to a complex architecture, with many actors and rules for 
eligibility. This complexity and lack of clarity make it difficult for the clients and 
for civil society to understand, and thus claim their rights. Even health staff can 
be confused by the plethora of policies, which are often poorly communicated and 
coordinated, leading to poor implementation and waste. Simultaneously, many 
countries are developing national health insurance schemes, and the relationship 
between insurance and exemption is rarely clearly defined.53 In Sudan, for 
example, one study found a cross-subsidy of insured patients by the exemption 
policy for pregnant women and under-fives, but this appeared to vary by 
locality.54 A similar problem has been identified in Burundi, where the civil 
servant insurance fund may have made big savings since the introduction of the 
free health care policy (as it is now the public budget which reimburses the 
facilities). The participants at the Bamako workshop reiterated the importance of 
having a coherent strategic vision for health financing, and the need to coordinate 
all health financing mechanisms to achieve the ultimate goal of universal 
coverage, through a sustainable system that develops over time to extend 
equitable access to health care for all.55 
Priorities for Further Research 	  
The rapid growth in exemption policies focused on these target groups opens up a 
number of important research questions (Table 4). In particular, there are 
outstanding questions on the cost-effectiveness of this strategy, compared to 
alternative approaches, and a need for further research on their sustainability 
and how they can be linked into broader health financing plans. 
 
Table 5: Outstanding Research Questions 
 
Policy drivers  
• Why were these particular policies developed?  
• What were the drivers?  
• What informed the different choices which countries made (situation 
analysis, research, priorities etc.)? 
• What was the balance of internal/external factors? 
• For international transfers, what were the mechanisms? 
• Are we now shifting towards a more juridical approach to health (human 
rights, recent constitutional changes etc.)?  
Impact on households 
• What impact have they had on household payments? 
o Formal and informal 
o In public and private sectors 
• What are the short and longer term economic and social impacts on the 
households? 
o Spending on other goods 
o Intra-household dynamics and allocation 
o Social relations 
Impact on health 
• How have the exemption schemes affected the quality of care? 
• How have they affected utilisation (taking into account secular trends, and 
any changes to reporting)? 
• What is their contribution to addressing the burden of mortality & 
morbidity? 
– Depends on services covered 
– Reaching right group 
– Delivered with appropriate care 
• To what extent have they had adverse effects (e.g. over-medicalisation with 
C-sections)? 
Impact on equity and access 
• How have the benefits of the policy been distributed, in terms of poorer 
women, women in more remote areas, and other marginalised groups? 
• Have they addressed the most significant access barriers? 
• Are the policies based on a consensus about priority groups? 
• How have they affected social solidarity? 
• How have they changed community perceptions and care seeking? 
Impact on staff 
• How well were staff working before? 
What margin was there for additional effort? 
• How has the removal of fees affected their financial rewards? 
• How has removal of fees affected their non-financial (and intrinsic) 
rewards and their motivation? 
Impact on facilities 
• What are the financial implications of selective removal of fees for the 
facilities?  
• How do they affect their accountability? 
• How have they adapted to it (threats and opportunities)? 
Impact on the health system 
• What impact has the free care had on the system as a whole? 
• Has it helped to integrate services or to fragment them? 
• Has it added to or diverted finance, staff time, and resources for other 
services? 
• Has it managed to catalyse wider health system strengthening? 
• How have different sectors and provider types been affected? 
How to set priorities 
• How can different criteria be traded off (e.g. greater coverage versus 
broader package of services)? 
• If you have limited funds, which services provide the best return? 
Cost-effectiveness of policies 
• What are the costs (total and marginal) of these policies? 
• What are their transaction costs? 
• What is the cost effectiveness of these policies?  
– These are financing policies, so often we are assessing not new 
services but changed incidence of costs, and/or improved 
distribution and/or improved quality 
• How do their marginal costs and benefits compare to alternative possible 
use of the funds? 
– Costs localised; effectiveness varies; also need to think about 
funding source and how transferable it might be 
Sustainability 
• Can the cost be sustained, now and as utilisation/coverage increases? 
• What support is likely to be forthcoming, especially after 2015? 
• What is the fit between exemption policies and overall health financing 
strategies? (Are they pulling together or pulling apart?) 
• Are there synergies with other strategies (e.g. performance-based funding, 
decentralisation etc)? 
 
Source: S. Witter, “Summary Presentation for Bamako Workshop,” 2011 
 
CONCLUSION 
Selective user fee removal was developed by governments to address the urgent 
needs of priority groups in a resource-constrained context. However, the thinking 
behind these policies needs to be re-examined, as well as their potential 
integration into the system as a whole. The basis for selecting particular services 
would benefit from a discussion of the balance of risks – C-sections address 
potentially catastrophic costs, for example, but do not necessarily address the 
main health risks to women. They also present iatrogenic risks and a distinct risk 
of unnecessary medicalization. Ideally, packages of care should integrate care of 
mother and the newborn to a higher degree than happens at present. Preventive 
elements, such as family planning and antenatal care should also be part of the 
package, if possible, as they are highly cost-effective.56-57 For households, some 
costs which are very important barriers, such as transport, have been neglected. 
 Each context will be different and it is not appropriate to prescribe specific 
packages here. However, it is important that all policies have clear objectives and 
are based on an inclusive dialogue about local priorities, risks and resources.58 
They should also learn from evidence and from one another – an important 
objective for the CoP and also for this article. Finally, the policies should fit into a 
clear national health-financing framework, not operate as stand-alone 
programmes with limited reflection about how they interact with other 
initiatives. Reducing fragmentation is the best way to reach UHC. 
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